{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:17:00Z","timestamp":1791357420487,"version":"4.3.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","prd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism & Related Disorders"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1016\/j.parkreldis.2009.02.015","type":"journal-article","created":{"date-parts":[[2009,4,6]],"date-time":"2009-04-06T04:34:10Z","timestamp":1238992450000},"page":"655-659","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["The current prevalence and factors associated with tardive dyskinesia among Filipino schizophrenic patients"],"prefix":"10.1016","volume":"15","author":[{"given":"Criscely L.","family":"Go","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond L.","family":"Rosales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rico J.","family":"Caraos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hubert H.","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.parkreldis.2009.02.015_bib1","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/01.nrl.0000038585.58012.97","article-title":"Classification and treatment of tardive syndromes","volume":"9","author":"Fernandez","year":"2003","journal-title":"Neurologist"},{"key":"10.1016\/j.parkreldis.2009.02.015_bib2","first-page":"33","article-title":"The epidemiology of tardive dyskinesia","volume":"Ch. 3","author":"Chong","year":"2004"},{"key":"10.1016\/j.parkreldis.2009.02.015_bib3","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/00004714-200202000-00005","article-title":"Tardive dyskinesia among Chinese and Malay patients with schizophrenia","volume":"22","author":"Chong","year":"2002","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.parkreldis.2009.02.015_bib4","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1176\/ajp.155.11.1521","article-title":"Prospective study of tardive dyskinesia in the elderly: rates and risk factors","volume":"155","author":"Woerner","year":"1998","journal-title":"Am J Psychiatry"},{"issue":"Suppl 14","key":"10.1016\/j.parkreldis.2009.02.015_bib5","first-page":"27","article-title":"Tardive dyskinesia in older patients","volume":"61","author":"Jeste","year":"2000","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.parkreldis.2009.02.015_bib6","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1600-0447.1993.tb03369.x","article-title":"Prevalence of tardive dyskinesia in samples of elderly people in Hong Kong","volume":"87","author":"Chiu","year":"1993","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.parkreldis.2009.02.015_bib7","series-title":"Schizophrenia","first-page":"305","article-title":"Electroconvulsive therapy and schizophrenia","author":"Krueger","year":"1995"},{"key":"10.1016\/j.parkreldis.2009.02.015_bib8","unstructured":"Fahn, S. A comprehensive review of movement disorders for the clinical practitioner. the tardive syndromes: phenomenology, concepts on pathophysiology, and treatment and other neuroleptic-induced syndromes. The Movement Disorders 14th Course. Aspen, CO. 2004. p. 191-247."},{"key":"10.1016\/j.parkreldis.2009.02.015_bib9","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1176\/appi.ajp.161.1.160","article-title":"Prevalence of neuroleptic-induced movement disorders in chronic schizophrenic in patients","volume":"161","author":"Janno","year":"2004","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.parkreldis.2009.02.015_bib10","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1001\/archpsyc.1982.04290040080014","article-title":"Research diagnoses for tardive dyskinesia","volume":"39","author":"Schooler","year":"1982","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.parkreldis.2009.02.015_bib11","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1176\/ajp.156.2.309","article-title":"Incidence of tardive dyskinesia in early stages of low dose treatment with typical neuroleptics in older patients","volume":"156","author":"Jeste","year":"1999","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.parkreldis.2009.02.015_bib12","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1093\/schbul\/18.4.701","article-title":"Gender differences in tardive dyskinesia: a critical review of literature","volume":"18","author":"Yassa","year":"1992","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.parkreldis.2009.02.015_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/oxfordjournals.schbul.a033302","article-title":"At issue: translating research into practice: the Schizophrenia Patient Outcomes Research Team (PORT) Treatment recommendations","volume":"24","author":"Lehman","year":"1998","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.parkreldis.2009.02.015_bib14","series-title":"Neuroleptic induced movement disorders. a comprehensive survey","author":"Yassa","year":"1997"},{"key":"10.1016\/j.parkreldis.2009.02.015_bib15","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/BF02191814","article-title":"Tardive dyskinesia in non-western countries: A review","volume":"246","author":"Ananda","year":"1995","journal-title":"Euro Arch Psychiatry Clin Neurosci"},{"key":"10.1016\/j.parkreldis.2009.02.015_bib16","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3109\/00048679109077725","article-title":"Tardive dyskinesia in elderly psychiatric patients in Singapore","volume":"25","author":"Tan","year":"1991","journal-title":"Aus NZ J Psychiatry"},{"key":"10.1016\/j.parkreldis.2009.02.015_bib17","first-page":"625","article-title":"Neuroleptic-induced tardive dyskinesia among Arab psychotic patients","volume":"13","author":"Osman","year":"2007","journal-title":"East Mediterr Health J"},{"key":"10.1016\/j.parkreldis.2009.02.015_bib18","first-page":"20","article-title":"The prevalence of neuroleptic drug-induced tardive movement subsyndromes among schizophrenic and schizoaffective patients residing in the southern region of Israel","volume":"4","author":"Lerner","year":"2007","journal-title":"Isr J Psychiatry Relat Sci"},{"key":"10.1016\/j.parkreldis.2009.02.015_bib19","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/00004714-198210000-00011","article-title":"Tardive dyskinesia in India: a prevalence study","volume":"2","author":"Doongaji","year":"1982","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.parkreldis.2009.02.015_bib20","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1176\/ajp.139.3.368","article-title":"Follow-up study on the reversibility of tardive dyskinesia","volume":"139","author":"Wegner","year":"1982","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.parkreldis.2009.02.015_bib21","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/00002826-198406000-00006","article-title":"The reversibility of \u201cpermanent\u201d tardive dyskinesia","volume":"7","author":"Klawans","year":"1984","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.parkreldis.2009.02.015_bib22","first-page":"250","article-title":"Neuroleptic-induced tardive dyskinesia and parkinsonism: change during several years of continuing treatment","volume":"22","author":"Casey","year":"1986","journal-title":"Psychopharmacol Bull"},{"key":"10.1016\/j.parkreldis.2009.02.015_bib23","doi-asserted-by":"crossref","first-page":"211","DOI":"10.2302\/kjm.34.211","article-title":"A 10-year follow-up study of tardive dyskinesia with special reference to the influence of neuroleptic administration on the long-term prognosis","volume":"34","author":"Yagi","year":"1985","journal-title":"Keio J Med"},{"key":"10.1016\/j.parkreldis.2009.02.015_bib24","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1055\/s-2007-971169","article-title":"Tardive dyskinesia","volume":"27","author":"Soares-Weiser","year":"2007","journal-title":"Semin Neurol"},{"key":"10.1016\/j.parkreldis.2009.02.015_bib25","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1600-0447.1993.tb03326.x","article-title":"Persistent tardive dyskinesia: demographic and pharmacological risk factors","volume":"87","author":"Muscettola","year":"1997","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.parkreldis.2009.02.015_bib26","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1176\/appi.ajp.161.8.1324","article-title":"Gender differences in the prescribing of antipsychotic drugs","volume":"161","author":"Seeman","year":"2004","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.parkreldis.2009.02.015_bib27","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1212\/WNL.56.6.805","article-title":"The course of tardive dyskinesia and parkinsonism in psychiatric inpatients: 14-year follow-up","volume":"56","author":"Fernandez","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2009.02.015_bib28","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1139\/jpn.0323","article-title":"Mythily. Smoking and tardive dyskinesia: lack of involvement of the CYP1A2 gene","volume":"28","author":"Chong","year":"2003","journal-title":"J Psychiatry Neurosci"},{"key":"10.1016\/j.parkreldis.2009.02.015_bib29","doi-asserted-by":"crossref","first-page":"27","DOI":"10.33393\/dti.2008.1326","article-title":"New-onset diabetes mellitus among parkinsonian patients treated with long-term quetiapine","volume":"3","author":"Fernandez","year":"2008","journal-title":"Drug Target Insights"},{"key":"10.1016\/j.parkreldis.2009.02.015_bib30","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.parkreldis.2004.04.007","article-title":"Diabetes mellitus among parkinsonian patients treated chronically with clozapine","volume":"10","author":"Fernandez","year":"2004","journal-title":"Parkinsonism Relat Disord"}],"container-title":["Parkinsonism & Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802009000601?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802009000601?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:11:14Z","timestamp":1761178274000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802009000601"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":30,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["S1353802009000601"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2009.02.015","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2009,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The current prevalence and factors associated with tardive dyskinesia among Filipino schizophrenic patients","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2009.02.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}